Alignment Healthcare (NASDAQ:ALHC) EVP Joseph Konowiecki Sells 25,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) EVP Joseph Konowiecki sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $24.00, for a total value of $600,000.00. Following the completion of the transaction, the executive vice president directly owned 1,103,816 shares in the company, valued at approximately $26,491,584. This represents a 2.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare Trading Up 0.8%

Alignment Healthcare stock opened at $24.01 on Thursday. The stock has a market cap of $4.96 billion, a P/E ratio of 266.78, a PEG ratio of 3.21 and a beta of 1.04. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.58 and a quick ratio of 1.58. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $24.12. The firm’s 50 day moving average price is $18.91 and its 200-day moving average price is $19.67.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. The firm had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.22 billion. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. Alignment Healthcare’s revenue for the quarter was up 33.3% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.05) earnings per share. On average, equities analysts predict that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ALHC. Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Wolfe Research initiated coverage on shares of Alignment Healthcare in a report on Friday, April 17th. They issued an “outperform” rating and a $24.00 target price for the company. Barclays decreased their price target on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Weiss Ratings raised shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. Finally, UBS Group increased their price target on shares of Alignment Healthcare from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $24.30.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ALHC. Summit Securities Group LLC bought a new stake in shares of Alignment Healthcare in the 4th quarter worth about $26,000. Parallel Advisors LLC grew its holdings in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after purchasing an additional 773 shares during the last quarter. Larson Financial Group LLC bought a new position in Alignment Healthcare during the 3rd quarter valued at about $33,000. First Horizon Corp purchased a new stake in Alignment Healthcare in the 4th quarter worth about $39,000. Finally, GAMMA Investing LLC raised its position in Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after purchasing an additional 987 shares during the period. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.